Moira Ringo
Director, Consulting
Moira comes to Clarivate with over 20 years of experience in healthcare industry and consulting, and focusses primarily on commercial strategy and market access. Moira began her career in GSK Research and Development after witnessing first-hand the power of medicine for a family member with cancer. At GSK she contributed to clinical development of over 20 assets, including the second approved personalized therapy for oncology. As she observed market access having an increasing role on product uptake, she transitioned to a role optimizing product strategy for newly launched and mature products at GSK, including supporting the launch of the first gene therapy for a rare disease.
Her consulting roles span US and global clinical, market access, and HEOR evidence strategy for advanced oncolytics, diagnostics, medical devices, and cell and gene therapies. She has developed robust channel, product, and market access strategies for the US market. Moira is passionate about uniting diverse client and consulting teams around the common goal of bringing science and technology to patients who need it.
Moira holds a PhD in chemistry from the University of Michigan and an MBA from the Duke Fuqua School of Business with a certificate in health sector management.
Latest news
Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI
New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom to operate, patentability, and infringement related decisions London, U.K. November 24, 2025. Clarivate Plc (NYSE:CLVT), a leading global provider…
Clarivate RiskMark Wins 2025 LegalTech Breakthrough Award For “LegalTech Predictive AI Solution of the Year”
Annual awards program recognizes companies and products driving innovation in the global legal technology industry AI-powered RiskMark delivers near-instant, data-backed insights London, U.K. November 13, 2025. Clarivate Plc (NYSE:CLVT), a…
